News / Health

Synthetic Malaria Drug Made Through Biotech, Yeast

A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
Jessica Berman
The World Health Organization says more than 200 million people - mostly in sub-Saharan Africa - were infected with malaria in 2010.  The mosquito-borne parasitic illness annually kills 650,000 people, a majority of them young children.

The most effective anti-malaria treatment developed so far is artemisinin, a plant-derived drug that is expensive and often unavailable.  Now, after a decade-long research effort, scientists have found a novel way to cheaply mass-produce artemisinin. The new, bio-synthetic version of the drug could be a major advance in the battle against malaria.

Whenever he travels to Africa, Jack Newman says he arrives prepared with his own supply of artemisinin.

“I always keep it in my back pocket in case I get malaria," said Newman. "Again, in three days you are cured.”

The American researcher hopes others infected with the parasitic illness might soon have easy access to the drug, too.

Newman is co-founder of Amyris, a U.S. biotechnology company that, in collaboration with researchers at the University of California Berkeley and the Canadian National Research Council, developed a process for making large quantities of a semi-synthetic version of artemisinin, offering people with uncomplicated malaria a cure in just three days.  

Artemisinin is a compound that until now has been derived exclusively from an ancient, bitter herb called wormwood.  It is up to 95 percent effective in curing uncomplicated malaria infections but, because it is derived from a plant, artemisinin is frequently in short supply, and expensive.

Newman and his colleagues figured out a way to make an unlimited supply of artemisinin using a technique that combines biotechnology and a simple yeast fermentation process.  

He says they extracted DNA from the wormwood plant and inserted it into yeast cells …

“..to fire up a big fermentation, like beer fermentation, but instead of making beer, you are actually making [an] anti-malarial drug," he said. "And you can do it in hundreds of thousands of gallons and, of course, make it in an industrial fashion, the same way we make penicillin;  very, very inexpensively.”

The process yields a chemical precursor to artemisinin, which is used in the production of the drug.

The innovation was made possible in large part by grants totaling $53.3 million from the Bill and Melinda Gates Foundation to the drug development arm of PATH, an international non-profit group that has been leading the fight against malaria and other diseases.  PATH helped move the artemisinin research out of the UC Berkeley labs to Amyris for scale-up, and then to the pharmaceutical company Sanofi Pasteur, for production of the yeast-based artemisinin. The company says it is distributing the drug free of charge.

Sanofi also plans to share the recipe with other drug makers so they, too, can use the technology to manufacture and distribute it on a “no profit, no loss” basis, according to Amyris's Jack Newman.

“Basically, by using synthetic biology, we’ve been able to stabilize the production so there’s always material available and make it at a very low cost," he said.

Newman says the yeast-based drug is identical to plant-derived artemisinin in terms of effectiveness. It is being formulated with a second anti-malaria compound to reduce the chances of drug resistance.

So far, Newman says, Sanofi plans to make 70 million doses of what he calls malaria “cures” this year. Using synthetic biology, next year the company will scale up production to 120 million doses, which will be distributed globally pending World Health Organization approval.

Jack Newman and his colleagues describe their production of a semi-synthetic version of the anti-malarial drug artemisinin in an article published in the journal Nature.  

You May Like

Ukraine Purges Interior Ministry Leadership With Pro-Russian Ties

Interior Minister Avakov says 91 people 'in positions of leadership' have been fired, including 8 generals found to have links to past pro-Moscow governments More

US Airlines Point to Additional Problems of any Ebola Travel Ban

Airline officials note that even under travel ban, they may not be able to determine where passenger set out from, as there are no direct flights from Liberia, Guinea or Sierra Leone More

Nigerian President to Seek Another Term

Goodluck Jonathan has faced intense criticism for failing to stop Boko Haram militants More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Talks to Resume on Winter Gas for Ukrainei
X
Al Pessin
October 25, 2014 4:21 PM
Ukrainian and Russian officials will meet again next week in an effort to settle their dispute over natural gas supplies that threatens to leave Ukraine short of heating fuel for the coming winter. VOA’s Al Pessin reports from London the dispute is complex, and has both economic and geopolitical dimensions.
Video

Video Talks to Resume on Winter Gas for Ukraine

Ukrainian and Russian officials will meet again next week in an effort to settle their dispute over natural gas supplies that threatens to leave Ukraine short of heating fuel for the coming winter. VOA’s Al Pessin reports from London the dispute is complex, and has both economic and geopolitical dimensions.
Video

Video Smugglers Offer Cheap Passage From Turkey to Syria

Smugglers in Turkey offer a relatively cheap passage across the border into Syria. Ankara has stepped up efforts to stem the flow of foreign fighters who want to join Islamic State militants fighting for control of the Syrian border city of Kobani. But porous borders and border guards who can be bribed make illegal border crossings quite easy. Zlatica Hoke has more.
Video

Video China Political Meeting Seeks to Improve Rule of Law

China’s communist leaders will host a top level political meeting this week, called the Fourth Plenum, and for the first time in the party’s history, rule of law will be a key item on the agenda. Analysts and Chinese media reports say the meetings could see the approval of long-awaited measures aimed at giving courts more independence and include steps to enhance an already aggressive and high-reaching anti-corruption drive. VOA’s Bill Ide has more from Beijing.
Video

Video After Decades of Pressure, Luxembourg Drops Bank Secrecy Rules

European Union finance ministers have reached a breakthrough agreement that will make it more difficult for tax cheats to hide their money. The new legislation, which had been blocked for years by countries with a reputation as tax havens, was approved last week after Luxembourg and Austria agreed to lift their vetoes. But as Mil Arcega reports, it doesn’t mean tax cheats have run out of places to keep their money hidden.
Video

Video Kobani Refugees Welcome, Turkey Criticizes, US Airdrop

Residents of Kobani in northern Syria have welcomed the airdrop of weapons, ammunition and medicine to Kurdish militia who are resisting the seizure of their city by Islamic State militants. The Turkish government, however, has criticized the operation. VOA’s Scott Bobb reports from southeastern Turkey, across the border from Kobani.
Video

Video US ‘Death Cafes’ Put Focus on the Finale

In contemporary America, death usually is a topic to be avoided. But the growing “death café” movement encourages people to discuss their fears and desires about their final moments. VOA’s Jerome Socolovsky reports.
Video

Video Ebola Orphanage Opens in Sierra Leone

Sierra Leone's first Ebola orphanage has opened in the Kailahun district. Hundreds of children orphaned since the beginning of the Ebola outbreak face stigma and rejection with nobody to care for them. Adam Bailes reports for VOA about a new interim care center that's aimed at helping the growing number of children affected by Ebola.

All About America

AppleAndroid